STOCK TITAN
  1. Home
  2. News
  3. OCEA

Ocean Biomedical Inc. Stock Price, News & Analysis

OCEA Nasdaq

Welcome to our dedicated page for Ocean Biomedical news (Ticker: OCEA), a resource for investors and traders seeking the latest updates and insights on Ocean Biomedical stock.

Ocean Biomedical Inc. (OCEA) is a biopharmaceutical innovator developing targeted therapies for oncology, fibrosis, and infectious diseases. This page provides investors and researchers with essential updates on clinical advancements, strategic partnerships, and regulatory milestones.

Access the latest press releases detailing OCEA's progress in immune checkpoint modulation and small molecule therapeutics. Stay informed about developments in bispecific antibody candidates targeting PD-1/CTLA-4 pathways and Chit1-focused fibrosis treatments.

Key updates include clinical trial progress, research collaborations, and scientific publications. Bookmark this page for real-time insights into OCEA's work addressing unmet medical needs through antibody engineering and molecular discovery.

News

Ocean Biomedical (NASDAQ: OCEA) Share Price Target Now Averaging $18.21, Based on Research and Development Progress in Three Promising Programs Generating Novel Treatment Candidates for Cancer, Malaria, and Fibrosis.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.41%
Tags
none
-
News

Ocean Biomedical, Inc. (NASDAQ: OCEA) Celebrates 95% Lung Cancer Tumor Reduction Results on World Lung Cancer Day

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.64%
Tags
none
-
News

Ocean Biomedical’s (NASDAQ: OCEA) mRNA-based Vaccine Candidate Generates Over 90% Killing of Malaria Parasites in Non-human Primates, Demonstrating Broad Potential for Ocean’s Program to Address Global and Emerging U.S. Malaria Challenges

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.42%
Tags
acquisition
News

Ocean Biomedical, Inc. Joins the Russell 2000® Index

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-9.77%
Tags
none
-
News

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces U.S. Patent Issued for Bispecific Cancer Immunotherapy Treatment With Demonstrated Killing of Tumor Cells in Lung Cancer, Brain Cancer (Glioblastoma), and Metastatic Melanoma.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5%
Tags
none
-
News

Ocean Biomedical (NASDAQ: OCEA) Extends Patent Rights for Breakthrough Idiopathic Pulmonary Fibrosis Discovery To Europe

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.34%
Tags
none
News

Ocean Biomedical (NASDAQ: OCEA) Announces Share Price Target Increase to $17.63 by Fundamental Research Corp. on Positive Results from Independent Study Showing Glioblastoma Tumor Suppression, Received Patents, and Recent Financing

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
27.26%
Tags
none
-
News

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Malaria Vaccine Patent Granted in Brazil, the 25th Patent Allowance for Programs in Infectious Disease, Cancer and Fibrosis

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
none
-
News

Ocean Biomedical (NASDAQ: OCEA) Announces Initiation of Coverage by Taglich Brothers with a Share Price Target of $20.

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.92%
Tags
none
News

Ocean Biomedical, Inc. (NASDAQ: OCEA) Announces Addition to the Russell 2000® Index

Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.6%
Tags
none

FAQ

What is the current stock price of Ocean Biomedical (OCEA)?

The current stock price of Ocean Biomedical (OCEA) is $0.0101 as of May 8, 2025.

What is the market cap of Ocean Biomedical (OCEA)?

The market cap of Ocean Biomedical (OCEA) is approximately 6.8M.
Stock OCEA logo
Ocean Biomedical Inc.

Nasdaq:OCEA

OCEA Rankings

N/A Ranked by Market Cap
N/A Ranked by Dividends

OCEA Stock Data

6.84M
142.05M
17.04%
2.6%
4.07%
Biotechnology
Pharmaceutical Preparations
Link
United States
NEW YORK